Loading...

Nisha Raj Revirajan

TitleSr. Clin Rsch Coordinator
SchoolUCSF School of Medicine
DepartmentNeurology
Address675 Nelson Rising Lane
San Francisco CA 94158
Phone415-502-7220
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Kerala University, IndiaMBBS2000T D Medical College
    ACRPCCRC2009

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nourbakhsh B, Revirajan N, Waubant E. Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis. JAMA Neurol. 2015 Nov; 72(11):1374-5. PMID: 26551959.
      View in: PubMed
    2. Bhargava P, Steele SU, Waubant E, Revirajan N, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM. Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler. 2016 May; 22(6):753-60. PMID: 26286698; PMCID: PMC4758937 [Available on 05/01/17].
    3. Maghzi AH, Graves J, Revirajan N, Spain R, Liu S, McCulloch CE, Pelletier D, Green AJ, Waubant E. Retinal axonal loss in very early stages of multiple sclerosis. Eur J Neurol. 2015 Jul; 22(7):1138-41. PMID: 25929276.
      View in: PubMed
    4. Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord. 2014 Nov; 3(6):720-7. PMID: 25891551.
      View in: PubMed
    5. Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D. A randomized controlled phase II trial of riluzole in early multiple sclerosis. Ann Clin Transl Neurol. 2014 May; 1(5):340-7. PMID: 25356404; PMCID: PMC4184685.
    Back to TOP